Butyrylcholinesterase accelerates cocaine metabolism: In vitro and in vivo effects in nonhuman primates and humans

Drug Metabolism and Disposition

Volumn 28, Issue 3, 2000, Pages 367-371

  Carmona, Gilberto N ^a   Jufer, Rebecca A ^a   Goldberg, Steven R ^a   Gorelick, David A ^a   Greig, Nigel H ^b   Yu, Qian Sheng ^b   Cone, Edward J ^a   Schindler, Charles W ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; CHOLINESTERASE; COCAINE; ECGONINE METHYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; SQUIRREL MONKEY;

ANIMALS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLIC CLEARANCE RATE; NARCOTICS; PLASMA; SAIMIRI; TETRAISOPROPYLPYROPHOSPHAMIDE;

ANIMALIA; EQUUS CABALLUS; PRIMATES; SAIMIRI; SCIURIDAE;

EID: 0034062037     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Borne RF, Bedford JA. Buelke JL, Craig CB, Hardin TC, Kibbe AH and Wilson MC (1977). Biological effects of cocaine derivatives. I: Improved synthesis and pharmacological evaluation of norcocainc. J Pharm Sci 66:119-120.
2. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV and Lenz DE (1991) Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 259:633-638.
3. Brzezinski MR, Abraham TL, Stone CL, Dean RA and Bosron WF (1994) Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem Pharmacol 48:1747-1755.
4. Carmona GN, Baum I, Schindler CW, Goldberg SR, Jufter R, Cone EJ, Belendiuk GW and Gorelick DA (1996) Plasma butyrylcholinesterase activity differs significantly in rhesus and squirrel monkeys. Life Sci 59:939-943.
5. Carmona GN, Schindler CW, Shoaib M, Jufter R, Cone EJ, Goldberg SR, Greig NH, Yu QS and Gorelick DA (1998) Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase. Experimental and Clinical Psychopharmacology 6:274-279.
6. Cone EF, Hillsgrove M and Darwin WD (1994) Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin Chem 40:1299-1305.
7. Dean RA, Christian CD, Sample RHB and Bosron WF (1991) Human liver cocaine esterases: Ethanol-mediated formation of ethylcocaine. FASEB J 5:2735-2739.
8. Devenyi P (1989) Cocaine complications and pseudocholinesterase. Ann Intern Med 110:167-168.
9. Erzouki HK, Baum I, Goldberg SR and Schindler CW (1993) Comparison of the effects of cocaine and its metabolites on cardiovascular function in anesthetized rats. J Cardiovasc Pharmacol 22:557-563.
10. Gorelick DA (1997) Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug Alcohol Depend 48:159-165.
11. Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L and Goldfrank LR (1992a) Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 21:247-253.
12. Hoffman RS, Henry GC, Wax PM, Weisman RS, Howland MA and Goldfrank LR (1992b) Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J Pharmacol Exp Ther 263:698-702.
13. Hoffman RS, Morasco R and Goldfrank LR (1996) Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. J Toxicol Clin Toxicol 34:259-266.
14. Konkol RJ, Erickson BA, Doerr JK, Hoffman RG and Madden JA (1976) Seizures induced by the cocaine metabolite benzoylecgonine in rats. Epilepsia 33:420-427.
15. Lynch TJ, Mattes CE, Singh A, Bradley RM, Brady RO and Dretchen KL (1997) Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol Appl Pharmacol 145:363-371.
16. Madden JA and Powers RH (1990) Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sci 47:1109-1114.
17. Mattes C, Lynch TJ, Singh A, Bradley RM, Kellaris PA, Brady RO and Dretchen KL (1997) Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol Appl Pharmacol 145:372-380.
18. Om A, Ellahham S, Ornato JP, Picone C, Theogaraj J, Corretjer GP and Vetrovec GW (1993) Medical complications of cocaine: Possible relationship to low plasma cholinesterase enzyme. Am Heart J 125:1114-1117.
19. Pindel EV, Kedishvili NY, Abraham TL, Brzezinski MR, Zhang J, Dean RA and Bosron WF (1997) Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J Biol Chem 272:14769-14775.
20. Washington C, Carmona GN, Woosley R, Dretchen K, Singh A, Montoya I and Gorelick DA (1996) Plasma butyrylcholinesterase activity in substance abusers. NIDA Res Monogr 162:255.
21. Xie W, Altamirano CV, Bartels CF, Speirs RJ, Cashman JR and Lockridge O (1999) An improved cocaine hydrolase: The A328Y mutant of human butyrylcholinesterase is 4-fold more efficient. Mol Pharmacol 55:83-91.